Show Notes
Understand the risks of handling cytotoxic drugs (cancer medications) and learn how to protect yourself as a healthcare worker.
Intro
* Cytotoxic drugs target rapidly dividing cells, but also affect healthy cells.
* Not just strong chemo – includes hormone therapies, antivirals, and more.
* Exposure routes: inhalation, skin contact, injection, patient fluids.
* Health effects: nausea, hair loss, infertility, organ damage, secondary cancers.
Segment 2: Risk Assessment
* HSE guidelines are your roadmap (See HSE Safe Handling of Cytotoxic Drugs 2022 Policy: https://healthservice.hse.ie/filelibrary/staff/hse-guideline-on-the-safe-handling-and-use-of-cytotox-drugs.pdf)
* List ALL hazardous drugs you use.
* Identify at-risk groups: pharmacy, nurses, cleaning staff, others.
* Break down the drug's journey to pinpoint exposure risks.
Segment 3: Control Measures
* Hierarchy of controls: eliminate, substitute, engineer, procedures, PPE (last resort).
* Engineering controls: ventilation, negative pressure rooms, closed-system transfer devices.
* PPE: specialized gloves, gowns, eye protection, maybe respirators.
Segment 4: Staff Training
* Training is essential, not optional.
* Includes knowledge, specific skills, and evolving procedures.
* Mix up formats: demos, scenarios, spill simulations.
* Competency checks: observation, assessments.
Segment 5: Where to Learn More
References
* HSE Safe Handling of Cytotoxic Drugs 2022 Policy (https://healthservice.hse.ie/filelibrary/staff/hse-guideline-on-the-safe-handling-and-use-of-cytotox-drugs.pdf)
Feedback form: https://forms.gle/Rgw59ofWL1b8SuNm8
IIOP CPD Example: https://docs.google.com/document/d/1WUYnhHblEtNeCVWgKutGynC44qwlxwLuRBzltiEW_wY/edit?usp=sharing
More from Irish Haematology Oncology Podcast
Eoin Tabb reports from Day 3 of the ISOPP CAPhO 2025 Symposium in Victoria, Canada. This episode delves into crucial discussions on Equity, Diversity, and Inclusion (EDI) in pharmacy practice, the benefits and risks of Artificial Intelligence (AI) in oncology, updates on preventing Cancer-Associated Thrombosis (CAT), and the implementation of pre-therapeutic Pharmacogenomics (PGx), including combining DPYD testing with Therapeutic Drug Monitoring (TDM) for 5-FU. Plus, hear exciting news from the ISOPP AGM about next year's unique 24-hour virtual conference format and a special collaboration with the Irish Pharmacy Haematology Oncology Society (IPHOS)! #ISOPPCAPhO2025 #OncologyPharmacy #Haematology #ClinicalPharmacy #EDI #AI #PGx #TDM #CAT CAT Survey: https://redcap.alfredhealth.org.au/redcap/surveys/index.php?s=dFo7DpNgVBauTYeW&__startover=1
Join Eoin Tabb for the second daily dispatch from the ISOPP CAPhO 2025 Symposium in Victoria, Canada. Day 2 covered a wide spectrum of crucial topics for haematology/oncology pharmacy practice. Highlights include practical management strategies for PARP inhibitors, the importance of cultural humility and discussing traditional medicines, ISOPP's new global service level framework, pharmacy's role in disaster preparedness and environmental sustainability, efficiencies in myeloma treatment administration (pre-meds, infusion times, schedules), managing CMV infections, considerations for treating older/unfit patients using geriatric assessment, and critical updates on hazardous drug lists and safety. Tune in for key insights and takeaways relevant to Irish practice! #ISOPPCAPhO2025 #OncologyPharmacy #Haematology #ClinicalPharmacy PARPi Clinical Resource: https://cdn.ymaws.com/www.cano-acio.ca/resource/resmgr/endorsements/en_parp_inhibitor_clinical_r.pdf
Join host Eoin Tabb for a special dispatch episode recorded live from the ISOPP 2025 Symposium in Victoria, BC. Get your 'audio delegate bag' with key insights from Day 1, covering: